Page 8 - Predicting survival in patients with spinal bone metastasesL
P. 8
CONTENTS
Chapter I Chapter II
Chapter III
Chapter IV
General introduction 9
A systematic review of prognostic factors predicting 17 survival in patients with spinal bone metastases.
L Bollen, WCH Jacobs, YM van der Linden,
O van der Hel, W Taal, PDS Dijkstra.
Eur Spine J. 2018;27(4):799-805.
Risk factors for survival in 106 surgically treated patients 31 with symptomatic spinal epidural metastasis.
L Bollen, GCW de Ruiter, W Pondaag , MP Arts,
M Fiocco, TJT Hazen, WC Peul, PDS Dijkstra.
Eur Spine J. 2013;22(6):1408-1416.
Prognostic factors associated with survival in patients 49 with symptomatic spinal bone metastases: a retrospective
cohort study of 1043 patients.
L Bollen, YM van der Linden, W Pondaag, M Fiocco,
BPM Pattynama, CAM Marijnen, RGHH Nelissen, WC Peul, PDS Dijkstra.
Neuro oncol. 2014;16(7):991-998.
Molecular phenotype is associated with survival in breast 69 cancer patients with spinal bone metastases.
L Bollen, C Wibmer, M Wang, YM van der Linden,
A Leithner, CE Bünger, AB Jensen, M Fiocco,
G Bratschitsch, W Pondaag, JVMG Bovée, PDS Dijkstra. Clin Exp Metastasis. 2015;32(1):1-5.
Chapter V
